Chemical classes identified as aprataxin inhibitors include a range of substances that indirectly influence the biological activity of aprataxin. Aprataxin itself is a nuclear protein with a role in DNA single-strand break repair through its involvement in the DNA ligation process. The protein's activity is tied to the broader network of DNA damage response and repair mechanisms. The listed chemicals exert their effects within these pathways, some targeting the kinase activities of ATM and ATR, which are pivotal in the signaling and repair of DNA damage, while others influence the repair machinery directly by inhibiting enzymes like DNA-PKcs and topoisomerases. These inhibitory actions may compromise the efficiency of DNA repair processes that aprataxin is a part of, thereby affecting its function.
The complexity of DNA repair pathways means that the inhibition of one component can have a cascade effect on the function of aprataxin. Additionally, PARP inhibitors alter the repair of single-strand breaks, which can indirectly affect aprataxin's activity by altering the substrate availability or demand for repair. While these chemicals are not direct inhibitors of aprataxin, their influence on the DNA damage response network provides a means by which aprataxin's activity may be modulated. The use of these chemicals, therefore, offers insight into the indirect modulation of aprataxin's role in DNA repair, although the specific consequences of such modulation on aprataxin activity would depend on the context of the cellular environment and the extent of DNA damage present
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine, a known phosphodiesterase (PDE) inhibitor, also affects the ATM/ATR kinases involved in DNA repair pathways. This inhibition can alter the phosphorylation state of proteins in the DNA damage response, potentially affecting aprataxin's function indirectly. | ||||||
ATM Kinase Inhibitor | 587871-26-9 | sc-202963 | 2 mg | $110.00 | 28 | |
KU-55933 is an ATM kinase inhibitor. Since ATM is involved in DNA damage response and aprataxin is part of the DNA repair mechanism, inhibition of ATM can indirectly affect the function of aprataxin by reducing its activation or recruitment to DNA damage sites. | ||||||
VE 821 | 1232410-49-9 | sc-475878 | 10 mg | $360.00 | ||
VE-821 is an ATR inhibitor. ATR, like ATM, is crucial in the response to DNA damage. Inhibition of ATR may result in a compromised DNA damage response, which may indirectly impact aprataxin's role in DNA repair. | ||||||
NU 7441 | 503468-95-9 | sc-208107 | 5 mg | $357.00 | 10 | |
NU7441 is a potent DNA-PKcs inhibitor. DNA-PKcs are key in non-homologous end joining, a DNA repair process. By inhibiting DNA-PKcs, NU7441 can indirectly affect aprataxin's activity, given aprataxin's role in DNA strand break repair. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is not only a PI3K inhibitor but also a known inhibitor of DNA-PKcs. This compound can indirectly decrease aprataxin's function by disrupting DNA repair pathways where DNA-PKcs plays a role. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin is a topoisomerase I inhibitor. By stabilizing the topoisomerase I-DNA cleavable complex, it introduces DNA breaks, potentially increasing the need for aprataxin function, thereby indirectly affecting its activity when overwhelmed. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide is a topoisomerase II inhibitor, which can increase double-strand breaks in DNA, indirectly affecting aprataxin activity by possibly overwhelming the repair capacity involving aprataxin. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
Olaparib is a PARP inhibitor, affecting single-strand break repair. Since aprataxin is involved in repair processes, inhibition of PARP can create an imbalance in the DNA damage response, potentially affecting aprataxin's role. | ||||||
Ceralasertib | 1352226-88-0 | sc-507439 | 10 mg | $573.00 | ||
AZD6738 is an inhibitor of ATR kinase. By inhibiting ATR, it can indirectly impact aprataxin's activity, as ATR is involved in signaling for the repair of DNA damage, which is aprataxin's functional domain. | ||||||
ATM/ATR Kinase Inhibitor Inhibitor | 905973-89-9 | sc-202964 | 5 mg | $106.00 | 8 | |
CGK733 is an inhibitor of ATM and ATR kinases. By simultaneously inhibiting both kinases, it can have a compounded effect on the DNA damage response, thereby indirectly influencing aprataxin activity. | ||||||